A Study to Compare MitoQ and Placebo to Treat Non-alcoholic Fatty Liver Disease (NAFLD)

PHASE2TerminatedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

July 31, 2011

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

DRUG

Mitoquinone mesylate

2 tablets to be taken daily upon wakening, with a glass of water and at least one hour before food.

DRUG

Placebo

Trial Locations (1)

Freeman Hospital, Newcastle upon Tyne